United Therapeutics Reports Q4 2025 Earnings with Revenue Growth and Pipeline Updates
United Therapeutics (UTHR) reported Q4 2025 revenue of $790 million, a 7% increase year-over-year, with full-year revenue surpassing $3 billion for the first time. The company also announced plans for a new product launch and upcoming pipeline data readouts.
Tickers: $UTHR
Topics: earnings report pipeline development product launch regulatory approval revenue growth